Agomelatine: A Preliminary Review of a New Antidepressant

Author： Zupancic Michael Guilleminault Christian

ISSN： 1172-7047

Source： CNS Drugs, Vol.20, Iss.12, 2006-01, pp. : 981-992

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation

Current Neuropharmacology, Vol. 8, Iss. 3, 2010-09 ,pp. : 287-304

Bentham Science Publishers

Access to resources Recommend Favorite

Role of melatonin in mood disorders and the antidepressant effects of agomelatine

By Srinivasan Venkataramanujam De Berardis Domenico Shillcutt Samuel D Brzezinski Amnon

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 10, 2012-10 ,pp. : 1503-1522

Informa Healthcare

Access to resources Recommend Favorite

A review of the efficacy and tolerability of agomelatine in the treatment of major depression

By Ghosh Anita Hellewell Jonathan SE

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1999-2004

Informa Healthcare

Access to resources Recommend Favorite

Melatonin Receptor Agonist Agomelatine: A New Drug for Treating Unipolar Depression

Current Pharmaceutical Design, Vol. 15, Iss. 14, 2009-05 ,pp. : 1675-1682

Bentham Science Publishers

Access to resources Recommend Favorite

Antidepressant market expanding in New Zealand

Inpharma, Vol. 1, Iss. 1281, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite